한국인에서 Vancomycin의 치료적 약물농도 평가

참고문헌 (18)

1. "Pharmacodynamics,pharmacokinetics,and therapeutic drug monitoring of glycopeptides", 20, pp.473~477 (1998)
2. "Therapeutic monitoring of antimicrobials:a summary of the information presented at the UK NEQAS for antibiotic assays meeting for participants", 35, pp.213~226 (1995)
3. "Analysis of vancomycin time-kill studies with statphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response", 36, pp.1766~9 (1992)
4. "Impact of vancomycin therapeutic drug monitoring on patient care", pp.1335~9 (1994)
5. "Serum vancomycin concentrations:Reappraisal of their clinical value", 18, pp.533~43 (1994)
6. "High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures", 45, pp.329~335 (2000)
7. "Evaluation of estimated and measured creatinine clearances for predicting the pharmacokinetics of vancomycin in adult liver transplant recipients", 25, pp.67~72 (2003)
8. "Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies", 60, pp.332~340 (1996)
9. "Clearance of vancomycin during high- volume haemofiltration:impact of pre-dilution", 28, pp.1664~1667 (2002)
10. "Pharmacokinetic optimization of vancomycin therapy", 28, pp.327~342 (1995)
11. "Vancomycin pharmacokinetics in patients with various degrees of renal function", 32, pp.848~852 (1998)
12. "Vancomycin and gentamicin in neonates : Hindsight, current controversies, and forethought", 16, pp.54~72 (2002)
13. "Vancomycin의 치료적 약물농도 측정", 32, pp.141~147 (2000)
14. "Potential benefit of bayesian forecasting for therapeutic drug monitoring in neonates", 24, pp.9~14 (2002)
15. "Fluorescence polarization immunoassay : Can it result in an overestimation of vancomycin in patients not suffering from renal failure?", 23, pp.441~444 (2001)
16. "Effect of analytical inaccuracy on dose adjustment for vancomycin,amikacin,and tobramycin using the abbott-base pharmacokinetic systems", 24, pp.696~700 (2002)
17. "Vancomycin monitoring; one or two serum levels?", 19, pp.614~619 (1997)
18. "Vancomycin therapeutic drug monitoring : is there a consensus view? The results of a UK National External Quality Assessment Scheme(UK NEQAS) for antibiotic assays questionnaire", 50, pp.713~718 (2002)